Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
TVTX

Overview Financials Analysis

Travere Therapeutics, Inc.

TVTX · NASDAQ

Analyze with AI

Filings0

Total reported value$0.0

Manager	Shares	Value	Change

No activity matches your filters yet.

Previous
Next

SymbolTVTX

Market Cap$3.2B

IPO Date2012-11-08

CEOEric Dube

Employees385

SectorHealthcare

IndustryBiotechnology

CountryUS

ExchangeNASDAQ Global Market

SMX (Security Matters) Public Limited Company

SMX · NASDAQ

$33.96

+76.14%

Regencell Bioscience Holdings Limited

RGC · NASDAQ

$52.88

+60.10%

Nuvve Holding Corp.

NVVE · NASDAQ

$3.51

+59.55%

Bristol-Myers Squibb Company Ce

CELG-RI · NYSE

$0.111

+58.80%

Innovative Eyewear, Inc.

LUCY · NASDAQ

$1.74

+47.46%

Peers

ASCENTAGE PHARMA GROUP INTERNATIONAL

AAPG · NASDAQ

$28.22

+8.50%

Apogee Therapeutics, Inc.

APGE · NASDAQ

$78.95

+0.89%

Celcuity Inc.

CELC · NASDAQ

$109.17

+3.95%

CG Oncology, Inc. Common stock

CGON · NASDAQ

$42.45

+5.15%

Centessa Pharmaceuticals plc

CNTA · NASDAQ

$22.69

+0.04%

Disc Medicine, Inc.

IRON · NASDAQ

$80.94

+4.63%

Legend Biotech Corporation

LEGN · NASDAQ

$22.72

+8.29%

Ultragenyx Pharmaceutical Inc.

RARE · NASDAQ

$24.20

+7.36%

Tarsus Pharmaceuticals, Inc.

TARS · NASDAQ

$78.08

-2.25%

Xenon Pharmaceuticals Inc.

XENE · NASDAQ

$42.12

+2.73%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.